HM-1 and ID8 mouse ovarian cancer cells expressed very low levels of VISTA, and the expression did not increase following treatment with IFN-γ, IL-4, IL-6, IL-10, IL-17, or TNF-α (Supplementary Figure 8A). This evidence concerns the gene IL17A and ovarian carcinoma.